Aquaporin-7 and glycerol permeability as novel obesity drug-target pathways

Trends Pharmacol Sci. 2006 Jul;27(7):345-7. doi: 10.1016/j.tips.2006.05.002. Epub 2006 Jun 9.

Abstract

Advances in determining the mechanisms that underlie the control of energy balance in mammals have recently been provided by the discovery and characterization of aquaporin-7 (AQP7), a water-glycerol transporter that is present in the plasma membrane of fat-storing cells (adipocytes). Recent studies have shown that the absence of AQP7 expression in fat cells increases glycerol kinase activity, boosting triacylglycerol synthesis and ultimately leading to obesity. Thus, AQP7 operates as a glycerol channel in vivo, whereby adipocyte glycerol permeability has a key role in the regulation of fat accumulation.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Obesity Agents / pharmacology*
  • Aquaporins / deficiency
  • Aquaporins / drug effects*
  • Aquaporins / physiology
  • Glycerol / metabolism*
  • Humans
  • Mice
  • Mice, Knockout

Substances

  • Anti-Obesity Agents
  • Aqp7 protein, mouse
  • Aquaporins
  • Glycerol